Molecular Partners AG
MLLCF
$4.22
-$0.06-1.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.63M | 6.80M | 8.89M | 7.64M | 7.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.63M | 6.80M | 8.89M | 7.64M | 7.80M |
| Cost of Revenue | 53.92M | 56.61M | 57.20M | 55.66M | 53.25M |
| Gross Profit | -48.29M | -49.81M | -48.31M | -48.03M | -45.45M |
| SG&A Expenses | 21.23M | 21.66M | 21.57M | 21.85M | 22.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.15M | 78.27M | 78.77M | 77.52M | 75.85M |
| Operating Income | -69.52M | -71.47M | -69.88M | -69.88M | -68.05M |
| Income Before Tax | -61.38M | -70.94M | -64.92M | -66.03M | -69.05M |
| Income Tax Expenses | 2.30K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -61.39 | -70.94 | -64.92 | -66.03 | -69.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.39M | -70.94M | -64.92M | -66.03M | -69.05M |
| EBIT | -69.52M | -71.47M | -69.88M | -69.88M | -68.05M |
| EBITDA | -67.19M | -69.17M | -67.57M | -67.57M | -65.77M |
| EPS Basic | -1.81 | -2.15 | -1.97 | -2.01 | -2.11 |
| Normalized Basic EPS | -1.13 | -1.34 | -1.23 | -1.26 | -1.32 |
| EPS Diluted | -1.82 | -2.15 | -1.97 | -2.01 | -2.11 |
| Normalized Diluted EPS | -1.13 | -1.34 | -1.23 | -1.26 | -1.32 |
| Average Basic Shares Outstanding | 136.13M | 132.10M | 131.74M | 131.39M | 131.08M |
| Average Diluted Shares Outstanding | 136.13M | 132.10M | 131.74M | 131.39M | 131.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |